510(k), De Novo and PMA: what "FDA cleared" does and doesn’t mean
Vendors often say a tool is "FDA approved" when it was cleared, or "FDA registered" when nothing was reviewed at all. The words matter, because each route asks for different evidence.
This explainer covers the three routes, what each one does and does not tell a buyer, and how to check a record on the FDA website. It is general information, not advice about any specific tool or patient.
Last reviewed November 2026 · Independent and vendor-neutral
The three routes to market
510(k): "cleared"
- The maker shows the device is "substantially equivalent" to a device already on the market (the predicate). FDA then clears it.
- It is by far the most common route for AI devices. Many 510(k) submissions rely on bench testing and retrospective data rather than new prospective clinical studies.
- Correct wording: "510(k) cleared". A 510(k) device is not "FDA approved".
De Novo: "granted"
- For a new kind of low- to moderate-risk device with no predicate. FDA reviews the risks and the controls that address them, then grants the request.
- A De Novo grant creates a new device type, and later tools can use it as their predicate for a 510(k).
- Correct wording: "De Novo granted" or "De Novo authorized".
PMA: "approved"
- Premarket approval is for the highest-risk (Class III) devices. The maker must provide valid scientific evidence, usually including clinical data, that the device is safe and effective.
- Few AI tools go this route. Only PMA devices are correctly called "FDA approved".
What clearance tells you, and what it doesn’t
It does tell you
- FDA reviewed the device for a stated intended use, and it can legally be marketed for that use.
- Which patients, inputs (scanner, ECG device, image type) and users the authorization covers. That is written in the indications for use.
It does not tell you
- That the tool improves patient outcomes, saves time or pays for itself. Clearance is about safety and effectiveness for the stated use, not value.
- How it performs on your patients, equipment or workflow. Local validation is still needed.
- Anything about uses outside the indications. Running it on other patients, settings or inputs is off-label for a device.
- Anything about data security, contracts or support. Those are separate questions.
Terms that sound like FDA review but aren’t
Watch for
- "FDA registered" or "FDA listed": the company registered its establishment or listed a product. FDA did not review the device.
- "Breakthrough Device designation": faster interaction with FDA during development. It is not an authorization to market.
- "Pending" or "submitted": no decision yet. Ask for the submission date and expect it can change.
- "Built on a cleared platform": the platform may be cleared for one use while the feature you’re buying is not. Check each function.
- "Not a device" or "exempt": some software is outside FDA device rules (see the clinical decision support explainer). That is a legal position, not a review.
How to check a record yourself
Steps
- Ask the vendor for the submission number: K followed by six digits for a 510(k), DEN for De Novo, P for PMA.
- Look it up in the FDA 510(k), De Novo or PMA database. Read the indications for use and the summary, and note the decision date and product code.
- Compare the cleared indication with how you plan to use it: patient group, inputs, user and whether it assists a clinician or acts on its own.
- Check whether the software version you’ll get is the one that was cleared, and whether the record mentions a predetermined change control plan (PCCP), which lets the maker make certain planned updates without a new submission.
- Search the FDA recall database for the device and company.